The Federal Minister for National Health Services Regulations & Coordination Aamer Mehmood Kiani on Thursday emphasised on the need of harmonisation and facilitation of Pharma export sector by engaging customs and Trade & Development Authority of Pakistan (TDAP) for resolution of their grievances. The federal minister stated in response to the concerns of the pharmaceutical industry, which was being represented by Pakistan Pharmaceutical Manufacturing Association and top 20 Pharma exporters of Pakistan. A meeting was held under the chairmanship of federal minister for health services with pharmaceutical exporters. The purpose of the meeting was to discuss mechanisms to boost the volume of pharmaceutical and alternative medicine exports. The federal minister said that Pharma sector has huge potential and needs harvesting for the benefit of the country by earning money abroad through improved exports of pharmaceutical and alternative medicine. It was also apprised that Pharma industry could expand its volume of exports as the sixth largest sector contributing to the overall exports of Pakistan. Pharma export sector is currently earning $230 million and has a potential to expand up to $2 billion. Drug Regulatory Authority of Pakistan (DRAP) Chief Executive Officer Dr Sheikh Akhtar Hussain apprised the federal minister that DRAP has already taken the initiative to facilitate local manufacturers who are exporting to other countries. This facilitation includes fast track registration, incentive of registration of one molecule against a $100,000 of export in a fiscal year, guidance and facilitation in issuance of regulatory documentation for the purpose of exports. Furthermore, DRAP is harmonising its regulatory function in line with international best practices for recognition and acceptance of local pharmaceutical industry abroad. The federal minister said that it can be boosted to achieve desired targets by engaging Pakistani missions abroad who will facilitate those Pakistani Pharma exporters in ease of doing business abroad after fulfilling the regulatory requirements of importing country. He also advised the Pharma sector to submit a working paper on how the export volume of this sector can be improved. DRAP CEO assured the Pharma industry that in order to further facilitate the exports, the authority will establish a separate desk for export purpose only where all the concerns of the exporters will be addressed regarding issuance of necessary documentation. DRAP will also facilitate the exporters for registration, enlistment and issuance of Good Manufacturing Practise certificate and certificate of pharmaceutical products. The CEO also assured the Pharma sector that DRAP is adamant at ensuring quality, safety and efficacy of medicine and every effort will be made to facilitate the industry in the ambit of the law. The boost in pharmaceutical and alternative medicine sector will also be able to bring new technologies and research and development laboratories in Pakistan. Published in Daily Times, September 28th 2018.